Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Application of Circulating Tumor DNA in Plasma of Patients with Primary Central Nervous System Lymphoma

Sang Eun Yoon, Won Seog Kim, MD PhD, Seok Jin Kim, MD PhD, Young Hyeh Ko, MD, Kim Yeon Jeong, PhD, Park Donghyun, PhD

Blood (2019) 134 (Supplement_1): 1491.

https://doi.org/10.1182/blood-2019-130075

Published: 2019

Journal Articles

Assessing the Utility of Immunoglobulin and T Cell Receptor Gene Rearrangement Studies for Cerebrospinal Fluid Specimens

Anna S Nam, MD, Amy Chadburn, MD, Wayne Tam, MD PhD

Blood (2017) 130 (Supplement 1): 4145.

https://doi.org/10.1182/blood.V130.Suppl_1.4145.4145

Published: 2017

Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD

Blood (2016) 128 (22): 649.

https://doi.org/10.1182/blood.V128.22.649.649

Published: 2016

Journal Articles

Initial Presentation Of Multiple Myeloma As Intraparenchymal Brain Mass

Ishan Malhotra, MBBS, Abhinav B. Chandra, MD, MSc, Yiwu Huang, MD, Ph.D.

Blood (2013) 122 (21): 5402.

https://doi.org/10.1182/blood.V122.21.5402.5402

Published: 2013

Journal Articles

Whole Brain Radiation Alone Brings the Favorable Outcomes for AIDS Related Primary Central Nervous System Lymphoma (PCNSL) Especially with Good Performance Status in the HAART Era.

Hirokazu Nagai, MD, Takashi Odawara, MD, Atsushi Ajisawa, MD, Shotaro Hagiwara, MD, Tomoko Uehira, MD, Hideki Uchiumi, MD, Mihoko Yotsumoto, MD, Toshikazu Miyakawa, MD, Akira Watanabe, MD, Mitsuru Konishi, MD, Seiji Saito, MD, Souichirou Takahama, MD, Masao Tateyama, MD, Seiji Okada, MD

Blood (2009) 114 (22): 4751.

https://doi.org/10.1182/blood.V114.22.4751.4751

Published: 2009

NARROW

Clinical Application of Circulating Tumor DNA in Plasma of Patients with Primary Central Nervous System Lymphoma

Assessing the Utility of Immunoglobulin and T Cell Receptor Gene Rearrangement Studies for Cerebrospinal Fluid Specimens

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Initial Presentation Of Multiple Myeloma As Intraparenchymal Brain Mass

Whole Brain Radiation Alone Brings the Favorable Outcomes for AIDS Related Primary Central Nervous System Lymphoma (PCNSL) Especially with Good Performance Status in the HAART Era.

Email alerts

ASH Publications

American Society of Hematology

Clinical Application of Circulating Tumor DNA in Plasma of Patients with Primary Central Nervous System Lymphoma

Assessing the Utility of Immunoglobulin and T Cell Receptor Gene Rearrangement Studies for Cerebrospinal Fluid Specimens

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Initial Presentation Of Multiple Myeloma As Intraparenchymal Brain Mass

Whole Brain Radiation Alone Brings the Favorable Outcomes for AIDS Related Primary Central Nervous System Lymphoma (PCNSL) Especially with Good Performance Status in the HAART Era.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only